Observational Study Designed to Detect Decompensation of Congestive Heart Failure (dCHF) Using a Non-Invasive Wearable Device

Part of paid clinical trials in Tampa, Florida.

Sponsor
CHFDX,Inc.
Study ID
NCT07350759
Status
Recruiting

Conditions

  • Decompensated Chronic Heart Failure

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • wearable ring device with multiple embedded sensors to detect heart rate, SVO2, respiratory rate, heart rate variability and a number of other related physiologic parameters — DEVICE
    In this observational study, a non-invasive, wearable ring used for continuous passive collection of physiologic data (sleep, activity, heart rate, HRV, temperature) will be used to collect data from all patients in the study. Data are used solely for research and algorithm development and are not used for diagnosis or treatment.

Study Details

This is a prospective, observational pilot study designed to develop a mathematical algorithm capable of predicting decompensation of congestive heart failure (dCHF) using physiologic data collected from a non-invasive wearable device. Participants with a remote hemodynamic pulmonary artery pressure monitor will wear a wearable device continuously for up to 12 months. Wearable data will be analyzed in relation to the hemodynamic monitor defined sentinel events of heart failure decompensation to identify predictive signal patterns. Optional biospecimen (DNA, blood, urine) and voice sample collection will support future biomarker discovery.

Key Dates

Start date
Mar 9, 2026
Status verified
Mar 2026
Primary completion
Dec 31, 2026
Completion
Dec 31, 2026

Study Design

Enrollment
60 participants (estimated)

Arms

  • Arm: Patients with congestive heart failure
    Patients will be monitored by a a tiny, battery-free pressure sensor implanted in a branch of the pulmonary artery via a right-heart catheterization, previously placed for a history of decompensating heart failure.

Primary Outcome Measure

Changes in multiple physiologic parameters from baseline that correlate with onset of dCHF [ Time Frame: Up to 12 Months ]

Central Contacts

Locations (2)

FacilityCityStateZIPSite coordinators
USFTampaFlorida33612
Robby Wu MD, MD
813-844-7000
USF Office of Clinical ResearchTampaFlorida33612-

Find similar trials in Tampa, FL